Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Hearings scheduled to consider single-payer healthcare in N.Y.

Six public hearings are scheduled to explore state legislation that would establish single-payer health insurance throughout New York, reports Ithaca Journal. 

U.S. healthcare spending growth slowest since 1960

U.S. healthcare spending rose 3.6 percent in 2013, which is the slowest rate on record since 1960, reports The Hill. 

HealthCare.gov’s small business insurance marketplace goes live

A year after postponing the launch of the small business part of HealthCare.gov, it has gone live with reports of only modest technical flaws, reports Washington Post.

Thumbnail

CMS to issue draft ACO regulations

The Centers for Medicare & Medicaid Services is expected to publish draft regulations to revise and expand the use of accountable care contracts under the Medicare Shared Savings Program, reports Modern Healthcare. 

Burwell calls for transparency following enrollment data error

Health & Human Services Secretary Sylvia Mathews Burwell is calling for “a culture of increased transparency” after Affordable Care Act enrollment data accidentally were inflated with dental plan customers, according to Bloomberg Businessweek.

Obama sued by House Republicans over ACA

Republications in the House of Representatives have filed a lawsuit against President Obama over the Affordable Care Act, reports Los Angeles Times.

DOJ recovers $2.3B in false claims

The Department of Justice has recovered $2.3 billion from alleged healthcare fraud schemes during fiscal year 2014, reports Modern Healthcare. 

Thumbnail

CMS launches new data and analytics office

The Centers for Medicare & Medicaid has formed a new Office of Enterprise Data and Analytics, which will help the agency better harness its vast data resources, reports Clinical Innovation + Technology.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup